• GIRENTUXIMAB chembl:CHEMBL1743027 Antineoplastic

    Alternate Names:

    WX-G250
    RENCAREX
    GIRENTUXIMAB
    CA9-SCAN CG250
    CG-250

    Drug Info:

    Drug Groups investigational
    Drug Type small molecule
    FDA Approval not approved
    Drug Class monoclonal antibody
    Drug Indications antineoplastic agent
    Drug Categories serum globulins
    Drug Categories proteins
    Drug Categories immunoproteins
    Drug Categories immunoglobulins
    Drug Categories globulins
    Drug Categories blood proteins
    Drug Categories antibodies
    Drug Categories amino acids, peptides, and proteins
    Drug Type biotech
    (1 More Sources)

    Publications:

  • Interaction Types & Directionality:
    n/a

    Interaction Info:
    Mechanism of Interaction Carbonic anhydrase IX other
    Direct Interaction yes

    Publications:

  • Interaction Types & Directionality:
    n/a

    Interaction Info:
    Trial Name WX-G250,Rencarex
    Novel drug target Novel Target

    Publications:

  • Interaction Types & Directionality:
    n/a

    Interaction Info:

    Publications:

    • Version: 5.1.7

    Alternate Names:
    GIRENTUXIMAB DrugBank Drug Name
    916138-87-9 CAS Number
    Rencarex Drug Brand

    Drug Info:
    Drug Type biotech
    Drug Groups investigational
    Drug Categories amino acids, peptides, and proteins

    Publications:

    • Version: January-2014

    Alternate Names:

    Drug Info:
    Drug Indications antineoplastic agent
    Drug Class monoclonal antibody
    FDA Approval not approved

    Publications:

    • Version: 2020.06.01

    Alternate Names:
    D0I8MT TTD Drug ID

    Drug Info:

    Publications:

    • Version: chembl_23

    Alternate Names:

    Drug Info:

    Publications:

    • Version: ChEMBL_27

    Alternate Names:

    Drug Info:

    Publications: